|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | -1.96% |
|
0.00% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.6667 | +33.33% | 3 | |||||||
| 62.03 | +102.97% | 16 | |||||||
| 5.061 | +73.72% | 17 | |||||||
| 2,979 | +27.31% | 10 | |||||||
| 33.72 | +70.45% | 12 | |||||||
| 350.38 | +50.21% | 8 | |||||||
| 125.87 | +30.17% | 9 | |||||||
| 47 | +8.29% | 6 | |||||||
| 24.49 | +52.38% | 8 | |||||||
| - | - | 1,415 | +205.94% | 1 | |||||
| 35.56 | +8.49% | 8 | |||||||
| 75.83 | +17.66% | 9 | |||||||
| 1,168.71 | +35.48% | 7 | |||||||
| 58.31 | +32.59% | 7 | |||||||
| 14.86 | +38.12% | 5 | |||||||
| - | 90 | +22.12% | 2 | ||||||
| - | 5,350 | +54.4% | 2 | ||||||
| Average | 696.26 | +50.80% | 8 | ||||||
| Weighted average by Cap. | 540.15 | +67.18% | 11 |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















